DUBLIN--(BUSINESS WIRE)--The "Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period.
The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and growth in stem cell and neurobiology research.
On the other hand, factors such as the costly and time-intensive antibody development process may hinder the growth of this market in the coming years.
Based on product type, the antibodies segment is expected to account for a larger share of the market in 2018 as well as grow at a higher CAGR during the forecast period. This can majorly be attributed to the increasing demand for accurate and reliable antibodies by research communities.
Based on cell type, in 2018, the T cell surface markers segment is expected to account for the largest share of the cell surface markers market. The large share of this segment is attributed to the high and growing use of T cell surface markers in research and diagnostics.
In 2018, North America is expected to account for the largest share of the cell surface markers market. North America has a well-established pharmaceuticals sector and currently dominates the cell surface markers market due to the increasing demand for the effective diagnosis and treatment of chronic diseases.
Market Dynamics
Drivers
- Increasing Funding for Life Science Research
- High Global Prevalence of Cancer
- Growth in Stem Cell and Neurobiology Research
Restraints
- Costly and Time-Intensive Antibody Development Process
Opportunities
- High Growth Opportunities in Emerging Markets
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cell Surface Markers Market, By Product
7 Cell Surface Marker Antibodies Market, By Source
8 Cell Surface Markers Market, By Cell Type
9 Cell Surface Markers Market, By Application
10 Cell Surface Markers Market, By End User
11 Cell Surface Markers Market, By Region
12 Competitive Landscape
13 Company Profiles
- Abcam
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Bio-Techne
- Biolegend
- Cell Signaling Technology
- Danaher Corporation
- F. Hoffman-La Roche
- Genscript
- Merk KGaA
- Qiagen N.V.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/w826zf/global_cell?w=4
